SCHEMBL7958265

SCHEMBL7958265

C/C=C/[CH]OC(=O)c1ccco1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.49
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.44
PKM P14618 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 2/20 0.43
MAOB P27338 1/20 0.43
TP53 P04637 1/20 0.43
HSD17B10 Q99714 2/20 0.43
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43
PTPN11 Q06124 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7756386 0.82 KMT2A (0.53) KMT2ACES2CES1SMN1; SMN2PKM
SCHEMBL1769910 0.77 KMT2A (0.55) KMT2ACES2CES1SMN1; SMN2PKM
SCHEMBL1203665 0.75 KMT2A (0.53) KMT2ACES2CES1SMN1; SMN2PKM
SCHEMBL3146758 0.75 KMT2A (0.49) KMT2ACES2CES1SMN1; SMN2NPC1
SCHEMBL28065903 0.73 KMT2A (0.47) KMT2ACES2CES1SMN1; SMN2PKM
SCHEMBL31159653 0.73 KMT2A (0.47) KMT2ACES2CES1SMN1; SMN2PKM
Acetic Acid SCHEMBL27592037 0.73 PTPN1 (0.50) KMT2ACES2CES1SMN1; SMN2PKM
SCHEMBL28230037 0.73 KMT2A (0.47) KMT2ACES2CES1SMN1; SMN2PKM
SCHEMBL363937 0.72
SCHEMBL30698159 0.72 KMT2A (0.69) KMT2ACES2CES1SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310060-B1 FOR USE AS ANTIPROLIFERATIVE AGENT FOR USE AGAINST CANCER, PSORIASIS, RESTENOSIS, AUTOIMMUNE DISEASE, OR ATHEROSCLEROSIS WARNER-LAMBERT COMPANY 2001-10-30 US disclosed